The Global Pharma Grade Dextrose Anhydrous Market was valued at USD 280 Million in 2025 and is projected to reach USD 410 Million by 2034, growing at a Compound Annual Growth Rate (CAGR) of 4.2% during the forecast period (2024–2030). This growth is being driven by the expansion of the global pharmaceutical industry, rising demand for parenteral nutrition and intravenous solutions, and the critical role of high-purity excipients in drug formulation.

As pharmaceutical manufacturing evolves with stricter quality standards and a focus on supply chain resilience, the spotlight is on the key ingredient suppliers who ensure the purity and efficacy of life-saving medications. In this blog, we profile the Top 10 Companies in the Pharma Grade Dextrose Anhydrous Industry—a mix of global starch giants, specialized chemical producers, and regional leaders shaping the future of pharmaceutical excipients.

Download FREE Sample Report:
Pharma Grade Dextrose Anhydrous Market – View in Detailed Research Report

---

🔟 1. Roquette Frères

Headquarters: Lestrem, France
Key Offering: Pharma Grade Dextrose Anhydrous (USP, EP, JP), Starch and Sugar Derivatives

Roquette Frères is a global leader in plant-based ingredients and a premier supplier of Pharma Grade Dextrose Anhydrous. With decades of expertise in starch derivatives, Roquette offers products that meet the most stringent international pharmacopeial standards. The company serves major pharmaceutical manufacturers worldwide, providing a critical ingredient for tablets, capsules, and injectable formulations.

Quality and Innovation Initiatives:

• Investment in advanced purification technologies for ultra-high purity dextrose

• Global manufacturing footprint with GMP-compliant facilities

• Strong R&D focus on developing customized excipient solutions for complex drug formulations

---

9️⃣ 2. Cargill, Incorporated

Headquarters: Wayzata, Minnesota, USA
Key Offering: Cargill Pharma Grade Dextrose Anhydrous, Bio-industrial products

Cargill is a major agricultural conglomerate with a significant presence in the pharmaceutical ingredients market. Its extensive grain processing operations provide a reliable raw material base for producing high-purity dextrose anhydrous. Cargill’s pharmaceutical division supplies excipients to a vast network of drug manufacturers, emphasizing traceability and supply chain security.

Quality and Innovation Initiatives:

• Integration of sustainable and traceable agricultural supply chains

• Commitment to consistent quality through rigorous process controls

---

8️⃣ 3. Archer-Daniels-Midland Company (ADM)

Headquarters: Chicago, Illinois, USA
Key Offering: ADM Pharma Grade Dextrose, Specialty Ingredients

ADM is a global leader in agricultural processing and a key producer of bio-based ingredients, including pharma grade dextrose anhydrous. Leveraging its massive grain origination and processing capabilities, ADM ensures a steady supply of high-quality dextrose for the pharmaceutical and nutraceutical industries. The company’s focus is on meeting exacting customer specifications and regulatory requirements.

Quality and Innovation Initiatives:

• Expansion of specialty ingredient portfolios for health and wellness

• Strategic investments in fermentation and bioprocessing technologies

---

7️⃣ 4. Ingredion Incorporated

Headquarters: Westchester, Illinois, USA
Key Offering: Pharma Grade Dextrose Anhydrous, Native and Modified Starches

Ingredion is a leading global ingredient solutions provider with a strong focus on the pharmaceutical sector. The company’s pharma grade dextrose anhydrous is known for its high purity and consistent performance. Ingredion works closely with pharmaceutical clients to provide technical support and ensure their excipient needs are met for a wide range of dosage forms.

Quality and Innovation Initiatives:

• Development of co-processed excipients for enhanced functionality

• Global quality systems aligned with cGMP standards

Download FREE Sample Report:
Pharma Grade Dextrose Anhydrous Market – View in Detailed Research Report

---

6️⃣ 5. Tate & Lyle PLC

Headquarters: London, United Kingdom
Key Offering: Pharma Grade Dextrose Anhydrous, Sweeteners, Texturants

Tate & Lyle is a renowned name in sweeteners and starches, with a dedicated focus on providing high-quality ingredients to the food, beverage, and pharmaceutical industries. The company’s pharmaceutical-grade dextrose is produced under strict quality controls and is a trusted excipient for tablet manufacturing and other pharmaceutical applications.

Quality and Innovation Initiatives:

• Portfolio transformation towards specialty food and pharmaceutical ingredients

• Focus on science-backed ingredients for health and wellness

---

5️⃣ 6. Grain Processing Corporation (GPC)

Headquarters: Muscatine, Iowa, USA
Key Offering: Pure-C dextrose anhydrous, Maltodextrins, Starches

Grain Processing Corporation (GPC), a subsidiary of Kent Corporation, is a specialist in corn refining and a significant supplier of pure, high-quality dextrose to the pharmaceutical industry. GPC’s products are valued for their consistent purity and performance, making them a preferred choice for critical pharmaceutical applications.

Quality and Innovation Initiatives:

• Specialization in corn-based ingredients with tight quality specifications

• Customer-centric approach with technical service and support

---

4️⃣ 7. Global Sweeteners Holdings Limited

Headquarters: Hong Kong
Key Offering: Pharmaceutical-grade dextrose, High-intensity sweeteners

Global Sweeteners Holdings is a key player in the Asia-Pacific region, supplying a range of sweeteners and starch-based products. The company produces pharma grade dextrose anhydrous that caters to the growing pharmaceutical manufacturing base in Asia, focusing on cost-effectiveness without compromising on quality.

Quality and Innovation Initiatives:

• Strategic location serving high-growth Asian markets

• Focus on scaling production to meet regional demand

---

3️⃣ 8. Tereos

Headquarters: Lille, France
Key Offering: Dextrose Anhydrous, Starch derivatives, Bio-ethanol

Tereos, a major European cooperative group, is a leading producer of sugar, starch, and alcohol products. Its industrial division produces pharma grade dextrose anhydrous, leveraging its expertise in carbohydrate chemistry. Tereos serves the European pharmaceutical market with a reliable supply of high-purity ingredients.

Quality and Innovation Initiatives:

• Utilization of co-products for a circular economy model

• Commitment to sustainable and responsible sourcing

---

2️⃣ 9. Sayaji Industries Limited

Headquarters: Ahmedabad, India
Key Offering: Dextrose Anhydrous (IP/BP/USP), Corn Starch, Sorbitol

Sayaji Industries is a prominent Indian manufacturer of starch and its derivatives. The company has a dedicated pharmaceutical vertical that produces dextrose anhydrous conforming to Indian Pharmacopoeia (IP), British Pharmacopoeia (BP), and United States Pharmacopeia (USP) standards. It is a key supplier to both domestic and international pharmaceutical companies.

Quality and Innovation Initiatives:

• Expansion of manufacturing capacities to meet growing export demand

• Focus on cost-competitive production for the generic drug market

---

1️⃣ 10. Zhucheng Xingmao Corn Developing Co., Ltd.

Headquarters: Shandong, China
Key Offering: Corn-based dextrose anhydrous, Maltodextrin, Modified starch

Zhucheng Xingmao is a leading Chinese producer of corn deep-processing products. The company manufactures pharma grade dextrose anhydrous and serves the vast pharmaceutical industry in China and neighboring countries. Its competitive pricing and large-scale production make it a significant player in the regional market.

Quality and Innovation Initiatives:

• Vertical integration from corn sourcing to finished product

• Investment in upgrading facilities to meet international quality standards

Get Full Report Here:
Pharma Grade Dextrose Anhydrous Market – View in Detailed Research Report

---

💊 Outlook: The Future of Pharma Grade Dextrose Anhydrous Is Rooted in Purity and Supply Chain Assurance

The pharma grade dextrose anhydrous market is undergoing a significant transformation. While the core product remains a fundamental excipient, the industry is increasingly focused on ultra-high purity standards, supply chain digitization, and strategic partnerships to ensure the integrity of the global pharmaceutical supply chain.

📈 Key Trends Shaping the Market:

• Rising demand for generic medicines and biosimilars, driving consistent excipient consumption

• Increased regulatory scrutiny requiring enhanced traceability and quality documentation

• Strategic shift towards regional supply chains to mitigate geopolitical and logistical risks

• Innovation in co-processed excipients that combine dextrose with other functional agents for superior performance

Get Full Report Here:
Pharma Grade Dextrose Anhydrous Market – View in Detailed Research Report

The companies listed above are not only supplying a critical pharmaceutical ingredient—they are underpinning the safety, efficacy, and accessibility of medicines worldwide.